Literature DB >> 16459644

Epithelioid sarcoma-like hemangioendothelioma: a case report.

Cigdem Tokyol1, Nüket Uzüm, Ilhami Kuru, Omer Uluoglu.   

Abstract

Seven cases of an unusual low-grade vascular tumor were reported in a recent study. Despite its similarity to epithelioid sarcoma, this tumor was termed epithelioid sarcoma-like hemangioendothelioma because of the subtle histopathological and immunohistochemical differences. Another case of this rare entity in a 70-year-old woman who suffered from a painful mass on the anterior aspect of the right cubital fossa is presented here, together with a review of the relevant literature.

Entities:  

Mesh:

Year:  2005        PMID: 16459644     DOI: 10.1177/030089160509100512

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  5 in total

1.  Pseudomyogenic hemangioendothelioma (epithelioid sarcoma-like hemangioendothelioma, fibroma-like variant of epithelioid sarcoma) of the thoracic spine.

Authors:  Michael McGinity; Viktor Bartanusz; Bradley Dengler; Lee Birnbaum; James Henry
Journal:  Eur Spine J       Date:  2013-02-24       Impact factor: 3.134

2.  A novel treatment for bone lesions of multifocal epithelioid sarcoma-like hemangioendothelioma.

Authors:  Adrian T Davis; A Mary Guo; Nancy J Phillips; David D Greenberg
Journal:  Skeletal Radiol       Date:  2015-01-08       Impact factor: 2.199

3.  Pseudomyogenic (Epithelioid sarcoma-like) hemangioendothelioma with bone invasion.

Authors:  Ahmet Karakasli; Ahmet Karaaslan; Mehmet Erduran; Sercan Capkin; Emine Burcin Tuna; Hasan Havitcioglu
Journal:  J Orthop       Date:  2014-07-30

4.  Solitary glomus tumor recurring as multiple glomus tumors.

Authors:  Maxime Freire; Brian Rubin; Steven Lietman; Murali Sundaram
Journal:  Skeletal Radiol       Date:  2012-06-26       Impact factor: 2.199

5.  Pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma of the lower limb: report of a rare case.

Authors:  Chuifeng Fan; Lianhe Yang; Xuyong Lin; Enhua Wang
Journal:  Diagn Pathol       Date:  2015-08-28       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.